{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:17:18Z","timestamp":1788297438777,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R01AG054839-01A1"],"award-info":[{"award-number":["1R01AG054839-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1R41AG087769-01A1"],"award-info":[{"award-number":["1R41AG087769-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008899","name":"University of South Carolina","doi-asserted-by":"publisher","award":["1P30GM154632"],"award-info":[{"award-number":["1P30GM154632"]}],"id":[{"id":"10.13039\/100008899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA263747-01A1"],"award-info":[{"award-number":["1R01CA263747-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.celbio.2026.100575","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:07:00Z","timestamp":1787756820000},"page":"100575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reverse the progression of Alzheimer\u2019s disease through Nano-ERASER-based adult neuroregeneration"],"prefix":"10.1016","author":[{"given":"Mingming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"VanderVeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan Annie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobo","family":"Mintzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4486-7058","authenticated-orcid":false,"given":"Peisheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2026.100575_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100158","article-title":"Ceria-nanocluster based therapy for Alzheimer's disease through the modulation of activated microglia and attenuation of amyloid-beta deposition","author":"Liu","year":"2025","journal-title":"Cell Biomater."},{"key":"10.1016\/j.celbio.2026.100575_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.celbio.2026.100575_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2026.100575_bib4","article-title":"Alzheimer's disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.celbio.2026.100575_bib5","article-title":"Donepezil for dementia due to Alzheimer's disease","volume":"6","author":"Birks","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.celbio.2026.100575_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.celbio.2026.100575_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2026.100575_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.celbio.2026.100575_bib9","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213483","article-title":"Incidence of Amyloid-Related Imaging Abnormalities in Phase III Clinical Trials of Anti-Amyloid-beta Immunotherapy: An Updated Meta-Analysis","volume":"104","author":"Jeong","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.celbio.2026.100575_bib10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.neuron.2019.08.009","article-title":"Inducing Different Neuronal Subtypes from Astrocytes in the Injured Mouse Cerebral Cortex","volume":"103","author":"Mattugini","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.celbio.2026.100575_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.stemcr.2014.10.007","article-title":"Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex","volume":"3","author":"Heinrich","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.celbio.2026.100575_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature12364","article-title":"Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing","volume":"500","author":"Xue","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100575_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70531","article-title":"Ptbp1 Knockdown in Glial Cells Promotes Motor and Sensory Function Recovery After Peripheral Nerve Injury","volume":"31","author":"Song","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.celbio.2026.100575_bib14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","article-title":"Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice","volume":"181","author":"Zhou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celbio.2026.100575_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","article-title":"Reversing a model of Parkinson's disease with in situ converted nigral neurons","volume":"582","author":"Qian","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100575_bib16","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.cell.2021.09.005","article-title":"Revisiting astrocyte to neuron conversion with lineage tracing in vivo","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celbio.2026.100575_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75636","article-title":"Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease","volume":"11","author":"Chen","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.celbio.2026.100575_bib18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/s41586-023-06066-9","article-title":"Ptbp1 deletion does not induce astrocyte-to-neuron conversion","volume":"618","author":"Hoang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100575_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.03.020","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"102","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.celbio.2026.100575_bib20","article-title":"Trim-Away in adult animals through Nano-ERASER and its application in cancer therapy","author":"Wang","year":"2023","journal-title":"Res. Sq."},{"key":"10.1016\/j.celbio.2026.100575_bib21","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","article-title":"A Method for the Acute and Rapid Degradation of Endogenous Proteins","volume":"171","author":"Clift","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celbio.2026.100575_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38273-3","article-title":"Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching","volume":"14","author":"Dawicki-McKenna","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100575_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11155","article-title":"Polypyrimidine tract binding protein 1 protects mRNAs from recognition by the nonsense-mediated mRNA decay pathway","volume":"5","author":"Ge","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.celbio.2026.100575_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-neuro-083022-113120","article-title":"Therapeutic Potential of PTB Inhibition Through Converting Glial Cells to Neurons in the Brain","volume":"46","author":"Fu","year":"2023","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.celbio.2026.100575_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01201","article-title":"The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation","volume":"3","author":"Li","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.celbio.2026.100575_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nn.4297","article-title":"Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells","volume":"19","author":"Xue","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celbio.2026.100575_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-024-02206-6","article-title":"Conversion of Astrocyte Cell Lines to Oligodendrocyte Progenitor Cells Using Small Molecules and Transplantation to Animal Model of Multiple Sclerosis","volume":"74","author":"Sharifi-Kelishadi","year":"2024","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.celbio.2026.100575_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.celbio.2026.100575_bib29","article-title":"Oligodendrocytes and myelination: pioneering new frontiers in cognitive neuroscience","volume":"19","author":"Zhang","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.celbio.2026.100575_bib30","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1242\/dev.126409","article-title":"How to make an oligodendrocyte","volume":"142","author":"Goldman","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.celbio.2026.100575_bib31","article-title":"Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.celbio.2026.100575_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2019.00076","article-title":"Distribution of alpha7 Nicotinic Acetylcholine Receptor Subunit mRNA in the Developing Mouse","volume":"13","author":"Broide","year":"2019","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.celbio.2026.100575_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-009-0513-4","article-title":"Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease","volume":"118","author":"Wang","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celbio.2026.100575_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(00)03075-4","article-title":"Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease","volume":"888","author":"Sasaki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.celbio.2026.100575_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2013.147","article-title":"Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celbio.2026.100575_bib36","series-title":"Stopping Alzheimer's before It Starts","author":"Miller","year":"2012"},{"key":"10.1016\/j.celbio.2026.100575_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-3-030-42667-5_8","article-title":"Early diagnosis and targeted treatment strategy for improved therapeutic outcomes in Alzheimer\u2019s disease","volume":"1260","author":"Guest","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.celbio.2026.100575_bib38","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijbiomac.2022.03.203","article-title":"Functionalized nanoparticles for brain targeted BDNF gene therapy to rescue Alzheimer's disease pathology in transgenic mouse model","volume":"208","author":"Arora","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.celbio.2026.100575_bib39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305056232600231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S305056232600231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:41:18Z","timestamp":1788295278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S305056232600231X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S305056232600231X"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100575","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse the progression of Alzheimer\u2019s disease through Nano-ERASER-based adult neuroregeneration","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100575","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100575"}}